Australia - English - Department of Health (Therapeutic Goods Administration)

recordati rare diseases australia pty ltd - mercaptamine (cysteamine), quantity: 3.8 mg/ml - eye drops, solution - excipient ingredients: carmellose sodium; benzalkonium chloride; disodium edetate; citric acid monohydrate; sodium hydroxide; hydrochloric acid; water for injections - cystadrops is indicated for the treatment of corneal cystine deposits in adults and children with cystinosis.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ausrichter pty ltd - dexamethasone 21 m sulfobenzoate sodium | mercaptamine hydrochloride | sorbic acid | propylparaben | methyl hydroxybenzoate | vitamin c = ascorbic acid - v11c + v13e * vet - cattle | goat | horse | sheep | beef | billy | bos indicus | bos taurus | bovine | buck | buffalo | bull | bullock | calf | capr - not applicable (vet)

Israel - English - Ministry of Health

medison pharma ltd - cysteamine as bitartrate - hard capsule - cysteamine as bitartrate 150 mg - mercaptamine - cystagon is indicated for the treatment of proven nephropathic cystinosis.cysteamine reduces cystine accumulation in some cells (e.g. leukocytes, muscle and liver cells) of nephropathic cystinosis patients and, when treatment is started early, it delays the development of renal failure.

Israel - English - Ministry of Health

medison pharma ltd - cysteamine as bitartrate - hard capsule - cysteamine as bitartrate 150 mg - mercaptamine - cystagon is indicated for the treatment of proven nephropathic cystinosis.cysteamine reduces cystine accumulation in some cells (e.g. leukocytes, muscle and liver cells) of nephropathic cystinosis patients and, when treatment is started early, it delays the development of renal failure.

Israel - English - Ministry of Health

medison pharma ltd - cysteamine as bitartrate - hard capsule - cysteamine as bitartrate 150 mg - mercaptamine - cystagon is indicated for the treatment of proven nephropathic cystinosis.cysteamine reduces cystine accumulation in some cells (e.g. leukocytes, muscle and liver cells) of nephropathic cystinosis patients and, when treatment is started early, it delays the development of renal failure.

Israel - English - Ministry of Health

medison pharma ltd - cysteamine as bitartrate - hard capsule - cysteamine as bitartrate 150 mg - mercaptamine - cystagon is indicated for the treatment of proven nephropathic cystinosis.cysteamine reduces cystine accumulation in some cells (e.g. leukocytes, muscle and liver cells) of nephropathic cystinosis patients and, when treatment is started early, it delays the development of renal failure.

Israel - English - Ministry of Health

medison pharma ltd - cysteamine as bitartrate - hard capsule - cysteamine as bitartrate 50 mg - mercaptamine - cystagon is indicated for the treatment of proven nephropathic cystinosis.cysteamine reduces cystine accumulation in some cells (e.g. leukocytes, muscle and liver cells) of nephropathic cystinosis patients and, when treatment is started early, it delays the development of renal failure.

Israel - English - Ministry of Health

medison pharma ltd - cysteamine as bitartrate - hard capsule - cysteamine as bitartrate 50 mg - mercaptamine - cystagon is indicated for the treatment of proven nephropathic cystinosis.cysteamine reduces cystine accumulation in some cells (e.g. leukocytes, muscle and liver cells) of nephropathic cystinosis patients and, when treatment is started early, it delays the development of renal failure.

Canada - English - Health Canada

horizon therapeutics ireland dac - cysteamine (cysteamine bitartrate) - capsule (delayed release) - 25mg - cysteamine (cysteamine bitartrate) 25mg - other miscellaneous therapeutic agents

Canada - English - Health Canada

horizon therapeutics ireland dac - cysteamine (cysteamine bitartrate) - capsule (delayed release) - 75mg - cysteamine (cysteamine bitartrate) 75mg - other miscellaneous therapeutic agents